JPRN-jRCT2080224649已完成1 期
A Phase I Multiple-Dose Study of RO7021610 in Japanese Patients with Ulcerative Colitis
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
It was suggested that RO7021610 has acceptable safety profile in Japanese UC patients.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Japanese patients with ulcerative colitis
- •- Diagnosis of ulcerative colitis established and confirmed at least 3 months prior to screening initiation
- •- Diagnosis of moderate-to-severe ulcerative colitis (Mayo endoscopic subscore >=2)
- •- Inadequate response, loss of response, or intolerance to prior treatment for moderate to severe ulcerative colitis
排除标准
- •- Confirmed or suspected diagnosis of colitis other than ulcerative colitis
- •- Diagnosis of ulcerative proctitis
- •- Prior and planned surgery for ulcerative colitis
- •- History of malignancy
研究者
相似试验
已完成
1 期
Phase I Study of RO7105705 in HV/AD patientsAlzheimer's diseaseJPRN-jRCT2080224616Chugai Pharmaceutical Co., Ltd.30
已完成
1 期
A Phase I Study of LJM716 in Japanese Patients With Advanced Solid TumorsNeoplasmsNCT01911936Novartis Pharmaceuticals12
已完成
1 期
A Study of LY2584702 in Solid TumorsCancerNCT01241461Eli Lilly and Company9
已完成
1 期
Study of LY2157299 in Japanese Participants With CancerNeoplasmsNeoplasm MetastasisNCT01722825Eli Lilly and Company12
已完成
1 期
Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese SubjectsAdvanced Solid MalignanciesCancerNCT01340040AstraZeneca10